S-337395: Clinical Trials

2 trials of S-337395, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Recruiting 1

Follow S-337395: new trials by email Literature Review of S-337395 trials Research Report on S-337395

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease
S-337395, Placebo - Respiratory Syncytial Virus Infections
Phase 2RecruitingShionogi1922025-12-112026-10-21
A Study to Investigate Different Formulations of S-337395 in Healthy Adult Participants
S-337395, Placebo - Healthy Volunteers
Phase 1CompletedShionogi502024-03-132024-07-10

Conditions studied

Respiratory Syncytial Virus Infections (1)  ·  Virus Diseases (1)

Sponsors

Shionogi (2)

Countries

United States (2)  ·  Argentina (1)  ·  Bulgaria (1)  ·  Japan (1)  ·  Poland (1)  ·  South Africa (1)  ·  Taiwan (1)  ·  Vietnam (1)